MMC - Medication and Enteral Drug Administration ...

For example, use of warfarin in conjunction with: - Inadequate or absent monitoring of PT/INR during treatment; and/or - Failure to recognize and monitor the increased risk of adverse . consequences when the resident is receiving other medications that are known to increase the risk of bleeding or to interact with warfarin and increase PT/INR. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download